Physician profile
Gregory K Dedinsky
NPI 1306934526
$2,380.45
in general payments reported to CMS, 2019-2025
9 companies · $56.09 in 2025
The $56.09 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $46.83 · 2021: $96.17 · 2022: $1,621 · 2023: $153 · 2024: $152 · 2025: $56.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,815.32 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $173.36 | 2019-2025 | Epic |
| Inari Medical, INC. | $130.23 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $77.49 | 2019 | |
| Atricure, INC. | $55.90 | 2021-2025 | Atriclip Laa Exclusion System |
| Zimmer Biomet Holdings, INC. | $52.35 | 2019-2023 | Sternalock Blu System |
| Abiomed | $34.53 | 2020 | |
| Getinge USA Sales, LLC | $24.03 | 2022 | |
| Medtronic, INC. | $17.24 | 2025 | Corevalve Evolut R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Dedinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.